| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 1.12e-08 | 37 | 86 | 6 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 1.32e-08 | 38 | 86 | 6 | GO:0070001 | |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 1.24e-05 | 11 | 86 | 3 | GO:0004523 | |
| GeneOntologyMolecularFunction | ABC-type sterol transporter activity | 1.83e-05 | 2 | 86 | 2 | GO:0034041 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 2.71e-05 | 14 | 86 | 3 | GO:0003964 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 9.70e-05 | 21 | 86 | 3 | GO:0035613 | |
| GeneOntologyMolecularFunction | RNA nuclease activity | 3.05e-04 | 136 | 86 | 5 | GO:0004540 | |
| GeneOntologyMolecularFunction | vasopressin receptor activity | 3.80e-04 | 7 | 86 | 2 | GO:0005000 | |
| GeneOntologyMolecularFunction | zinc ion binding | ERVK-6 PDE2A ENPP1 KAT6A ERVK-8 ERVK-19 ERVK-7 ERVK-21 ERVK-9 ZZEF1 NR1I3 PML | 4.23e-04 | 891 | 86 | 12 | GO:0008270 |
| GeneOntologyMolecularFunction | nuclease activity | 4.88e-04 | 231 | 86 | 6 | GO:0004518 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 5.39e-04 | 37 | 86 | 3 | GO:0016891 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 5.84e-04 | 38 | 86 | 3 | GO:0034061 | |
| GeneOntologyMolecularFunction | ATPase-coupled lipid transmembrane transporter activity | 6.47e-04 | 9 | 86 | 2 | GO:0034040 | |
| GeneOntologyMolecularFunction | angiotensin receptor binding | 8.07e-04 | 10 | 86 | 2 | GO:0031701 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 1.02e-03 | 46 | 86 | 3 | GO:0016893 | |
| GeneOntologyMolecularFunction | peptidase activity | ERVK-6 GGT6 TMPRSS11E USP24 ERVK-8 ERVK-19 ERVK-7 ERVK-21 ERVK-9 | 2.00e-03 | 654 | 86 | 9 | GO:0008233 |
| GeneOntologyBiologicalProcess | DNA integration | 1.87e-05 | 13 | 85 | 3 | GO:0015074 | |
| GeneOntologyBiologicalProcess | RNA-templated DNA biosynthetic process | 2.38e-05 | 83 | 85 | 5 | GO:0006278 | |
| GeneOntologyBiologicalProcess | cell-cell fusion | 2.67e-05 | 85 | 85 | 5 | GO:0140253 | |
| GeneOntologyBiologicalProcess | syncytium formation by plasma membrane fusion | 2.67e-05 | 85 | 85 | 5 | GO:0000768 | |
| GeneOntologyBiologicalProcess | syncytium formation | 3.34e-05 | 89 | 85 | 5 | GO:0006949 | |
| GeneOntologyBiologicalProcess | cellular response to high density lipoprotein particle stimulus | 1.00e-04 | 4 | 85 | 2 | GO:0071403 | |
| GeneOntologyBiologicalProcess | viral process | ERVK-6 AVPR1B TMPRSS11E ERVK-8 ERVK-19 ERVK-7 ERVK-21 ERVK-9 FUT8 | 1.24e-04 | 464 | 85 | 9 | GO:0016032 |
| GeneOntologyBiologicalProcess | regulation of systemic arterial blood pressure by vasopressin | 1.66e-04 | 5 | 85 | 2 | GO:0001992 | |
| GeneOntologyBiologicalProcess | peptidyl-tryptophan modification | 2.49e-04 | 6 | 85 | 2 | GO:0018211 | |
| GeneOntologyBiologicalProcess | protein C-linked glycosylation via tryptophan | 2.49e-04 | 6 | 85 | 2 | GO:0018317 | |
| GeneOntologyBiologicalProcess | protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan | 2.49e-04 | 6 | 85 | 2 | GO:0018406 | |
| GeneOntologyBiologicalProcess | protein C-linked glycosylation | 2.49e-04 | 6 | 85 | 2 | GO:0018103 | |
| GeneOntologyBiologicalProcess | DNA biosynthetic process | 2.84e-04 | 218 | 85 | 6 | GO:0071897 | |
| Domain | DUF4599 | 1.62e-05 | 12 | 80 | 3 | PF15371 | |
| Domain | DUF4599 | 1.62e-05 | 12 | 80 | 3 | IPR027970 | |
| Domain | ABCG1 | 1.81e-05 | 2 | 80 | 2 | IPR020064 | |
| Domain | DUF1856 | 1.81e-05 | 2 | 80 | 2 | IPR015076 | |
| Domain | DUF1856 | 1.81e-05 | 2 | 80 | 2 | SM01164 | |
| Domain | DUF1856 | 1.81e-05 | 2 | 80 | 2 | PF08983 | |
| Domain | Dpy19 | 1.08e-04 | 4 | 80 | 2 | PF10034 | |
| Domain | Dpy-19/Dpy-19-like | 1.08e-04 | 4 | 80 | 2 | IPR018732 | |
| Domain | ABC_2_trans | 1.80e-04 | 5 | 80 | 2 | IPR013525 | |
| Domain | Vasoprsn_rcpt | 1.80e-04 | 5 | 80 | 2 | IPR001817 | |
| Domain | ABC2_membrane | 1.80e-04 | 5 | 80 | 2 | PF01061 | |
| Domain | Ca/CaM-dep_Ca-dep_prot_Kinase | 3.24e-03 | 69 | 80 | 3 | IPR020636 | |
| Domain | ARM-type_fold | 3.33e-03 | 339 | 80 | 6 | IPR016024 | |
| Domain | Spectrin | 4.32e-03 | 23 | 80 | 2 | PF00435 | |
| Pubmed | 7.22e-11 | 12 | 88 | 5 | 14557543 | ||
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 1.91e-10 | 5 | 88 | 4 | 12629516 | |
| Pubmed | 5.72e-10 | 6 | 88 | 4 | 20850414 | ||
| Pubmed | Targeted disruption of the spermatid-specific gene Spata31 causes male infertility. | 5.72e-10 | 6 | 88 | 4 | 25930072 | |
| Pubmed | 6.25e-08 | 4 | 88 | 3 | 29713080 | ||
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 1.50e-07 | 94 | 88 | 6 | 21542922 | |
| Pubmed | 3.11e-07 | 6 | 88 | 3 | 15063128 | ||
| Pubmed | 3.91e-07 | 24 | 88 | 4 | 32212159 | ||
| Pubmed | 1.85e-06 | 10 | 88 | 3 | 12970426 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 15240127 | ||
| Pubmed | V1a receptor knockout mice exhibit impairment of spatial memory in an eight-arm radial maze. | 6.33e-06 | 2 | 88 | 2 | 15036628 | |
| Pubmed | The acute intoxicating effects of ethanol are not dependent on the vasopressin 1a or 1b receptors. | 6.33e-06 | 2 | 88 | 2 | 17049983 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 27228027 | ||
| Pubmed | Mice genetically deficient in vasopressin V1a and V1b receptors are resistant to jet lag. | 6.33e-06 | 2 | 88 | 2 | 24092737 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 25438555 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 27713143 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 9060628 | ||
| Pubmed | Evolutionary relationships within a subgroup of HERV-K-related human endogenous retroviruses. | 6.33e-06 | 2 | 88 | 2 | 9460924 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 10980608 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 9294197 | ||
| Pubmed | Both V(1A) and V(1B) vasopressin receptors deficiency result in impaired glucose tolerance. | 6.33e-06 | 2 | 88 | 2 | 19375419 | |
| Pubmed | Modulation of male mouse sociosexual and anxiety-like behaviors by vasopressin receptors. | 6.33e-06 | 2 | 88 | 2 | 30290180 | |
| Pubmed | Tissue and zonal-specific expression of an olfactory receptor transgene. | 6.33e-06 | 2 | 88 | 2 | 9412503 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 16556852 | ||
| Pubmed | Vasopressin regulation of blood pressure and volume: findings from V1a receptor-deficient mice. | 6.33e-06 | 2 | 88 | 2 | 19693000 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 18039927 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 9357056 | ||
| Pubmed | Structure and sequence of the mouse V1a and V1b vasopressin receptor genes. | 6.33e-06 | 2 | 88 | 2 | 10669045 | |
| Pubmed | Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations. | 1.71e-05 | 125 | 88 | 5 | 32891193 | |
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 9322919 | ||
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 10516026 | ||
| Pubmed | Promyelocytic leukemia zinc finger protein regulates interferon-mediated innate immunity. | 1.90e-05 | 3 | 88 | 2 | 19523849 | |
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 25302608 | ||
| Pubmed | Vasopressin mediates fructose-induced metabolic syndrome by activating the V1b receptor. | 1.90e-05 | 3 | 88 | 2 | 33320834 | |
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 9971820 | ||
| Pubmed | ABCG1 and ABCG4 Suppress γ-Secretase Activity and Amyloid β Production. | 1.90e-05 | 3 | 88 | 2 | 27196068 | |
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 22904064 | ||
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 18798339 | ||
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 16902247 | ||
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 38900750 | ||
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 11175338 | ||
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 17916878 | ||
| Pubmed | MCF-7 breast cancer cells express normal forms of all vasopressin receptors plus an abnormal V2R. | 1.90e-05 | 3 | 88 | 2 | 10477084 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ZNF462 ABCG1 SGSM1 ZBTB16 ARRB2 TRIO ARHGAP44 KAT6A OSBPL5 MACF1 PLA2G6 XRCC2 CNOT1 INVS | 2.16e-05 | 1489 | 88 | 14 | 28611215 |
| Pubmed | 3.79e-05 | 4 | 88 | 2 | 9581826 | ||
| Pubmed | 3.79e-05 | 4 | 88 | 2 | 11955056 | ||
| Pubmed | 3.79e-05 | 4 | 88 | 2 | 31159502 | ||
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 3.79e-05 | 4 | 88 | 2 | 10469592 | |
| Pubmed | 3.79e-05 | 4 | 88 | 2 | 15210959 | ||
| Pubmed | 3.79e-05 | 4 | 88 | 2 | 7983737 | ||
| Pubmed | 3.79e-05 | 4 | 88 | 2 | 26412716 | ||
| Pubmed | 4.40e-05 | 251 | 88 | 6 | 27507650 | ||
| Pubmed | Oxytocin Facilitates Allomaternal Behavior under Stress in Laboratory Mice. | 6.30e-05 | 5 | 88 | 2 | 35017259 | |
| Pubmed | Transcriptionally active HERV-K genes: identification, isolation, and chromosomal mapping. | 6.30e-05 | 5 | 88 | 2 | 11401426 | |
| Pubmed | Expression and functional characterization of ABCG1 splice variant ABCG1(666). | 6.30e-05 | 5 | 88 | 2 | 16870176 | |
| Pubmed | Oxytocin signaling in the medial amygdala is required for sex discrimination of social cues. | 6.30e-05 | 5 | 88 | 2 | 29231812 | |
| Pubmed | 6.30e-05 | 5 | 88 | 2 | 21705713 | ||
| Pubmed | 6.30e-05 | 5 | 88 | 2 | 26903624 | ||
| Pubmed | Mice lacking D5 dopamine receptors have increased sympathetic tone and are hypertensive. | 6.30e-05 | 5 | 88 | 2 | 12486173 | |
| Pubmed | Cholesterol efflux in megakaryocyte progenitors suppresses platelet production and thrombocytosis. | 6.30e-05 | 5 | 88 | 2 | 23584088 | |
| Pubmed | Molecular pharmacology and modeling of vasopressin receptors. | 6.30e-05 | 5 | 88 | 2 | 12436935 | |
| Pubmed | MOZ increases p53 acetylation and premature senescence through its complex formation with PML. | 9.43e-05 | 6 | 88 | 2 | 23431171 | |
| Pubmed | 9.43e-05 | 6 | 88 | 2 | 15968309 | ||
| Pubmed | 9.43e-05 | 6 | 88 | 2 | 18384079 | ||
| Pubmed | DYRK1A interacts with histone acetyl transferase p300 and CBP and localizes to enhancers. | 9.43e-05 | 6 | 88 | 2 | 30137413 | |
| Pubmed | 9.43e-05 | 6 | 88 | 2 | 10858434 | ||
| Pubmed | PDE2A CORO2B STAG1 TRIO MACF1 NBEA POGZ RAD54L2 CTNND2 FUT8 ZNF583 SEZ6L | 9.46e-05 | 1285 | 88 | 12 | 35914814 | |
| Pubmed | 9.47e-05 | 418 | 88 | 7 | 34709266 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PDE2A TRIO KIF26A ARHGAP44 KAT6A OSBPL5 CPSF1 PLA2G6 ZZEF1 ULK2 ARHGAP33 | 1.09e-04 | 1105 | 88 | 11 | 35748872 |
| Pubmed | DCDC1 KAT6A XRN1 MACF1 POGZ ZZEF1 KAT14 ARHGAP33 SEZ6L PML DCAF7 | 1.18e-04 | 1116 | 88 | 11 | 31753913 | |
| Pubmed | Physical and functional link of the leukemia-associated factors AML1 and PML. | 1.32e-04 | 7 | 88 | 2 | 15331439 | |
| Pubmed | CAR Suppresses Hepatic Gluconeogenesis by Facilitating the Ubiquitination and Degradation of PGC1α. | 1.32e-04 | 7 | 88 | 2 | 26407237 | |
| Pubmed | Calcitonin receptor signaling in the medial preoptic area enables risk-taking maternal care. | 1.32e-04 | 7 | 88 | 2 | 34077719 | |
| Pubmed | 1.32e-04 | 7 | 88 | 2 | 37844254 | ||
| Pubmed | ZNF462 PDE2A TRIO ARHGAP44 MACF1 DGKZ NBEA CTNND2 CNOT1 DCAF7 | 1.62e-04 | 963 | 88 | 10 | 28671696 | |
| Pubmed | K63-linked ubiquitination of DYRK1A by TRAF2 alleviates Sprouty 2-mediated degradation of EGFR. | 1.75e-04 | 8 | 88 | 2 | 34117217 | |
| Pubmed | 2.58e-04 | 222 | 88 | 5 | 37071664 | ||
| Pubmed | 2.68e-04 | 122 | 88 | 4 | 30773093 | ||
| Pubmed | 2.81e-04 | 10 | 88 | 2 | 20368512 | ||
| Pubmed | 3.31e-04 | 513 | 88 | 7 | 25798074 | ||
| Pubmed | Variants in LRRC7 lead to intellectual disability, autism, aggression and abnormal eating behaviors. | 3.43e-04 | 11 | 88 | 2 | 39256359 | |
| Pubmed | TOPORS-mediated RAD51 SUMOylation facilitates homologous recombination repair. | 3.43e-04 | 11 | 88 | 2 | 35061896 | |
| Pubmed | NANOS2 interacts with the CCR4-NOT deadenylation complex and leads to suppression of specific RNAs. | 4.85e-04 | 13 | 88 | 2 | 20133598 | |
| Pubmed | 4.85e-04 | 13 | 88 | 2 | 25178676 | ||
| Pubmed | 4.85e-04 | 13 | 88 | 2 | 26531127 | ||
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 5.29e-04 | 146 | 88 | 4 | 23892456 | |
| Pubmed | 5.65e-04 | 14 | 88 | 2 | 20584987 | ||
| Pubmed | Functional consequences of necdin nucleocytoplasmic localization. | 5.83e-04 | 64 | 88 | 3 | 22442722 | |
| Pubmed | Efficient transposition of the piggyBac (PB) transposon in mammalian cells and mice. | 7.42e-04 | 16 | 88 | 2 | 16096065 | |
| Pubmed | 7.42e-04 | 16 | 88 | 2 | 32460029 | ||
| Pubmed | Zfp423/OAZ participates in a developmental switch during olfactory neurogenesis. | 7.42e-04 | 16 | 88 | 2 | 17521568 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 7.53e-04 | 281 | 88 | 5 | 28706196 | |
| Pubmed | 7.64e-04 | 591 | 88 | 7 | 15231748 | ||
| Pubmed | 7.80e-04 | 162 | 88 | 4 | 15174051 | ||
| Pubmed | A method to identify cDNAs based on localization of green fluorescent protein fusion products. | 8.40e-04 | 17 | 88 | 2 | 10716735 | |
| Pubmed | 9.43e-04 | 18 | 88 | 2 | 18664271 | ||
| Pubmed | PDE2A CORO2B TRIO DOCK8 ARHGAP44 XRN1 MACF1 DGKZ NBEA CTNND2 CNOT1 | 9.66e-04 | 1431 | 88 | 11 | 37142655 | |
| Pubmed | 1.17e-03 | 20 | 88 | 2 | 22028030 | ||
| Pubmed | A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients. | 1.29e-03 | 21 | 88 | 2 | 24025145 | |
| Pubmed | 1.41e-03 | 22 | 88 | 2 | 35792897 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q12 | 9.87e-05 | 8 | 87 | 2 | chr9q12 | |
| Cytoband | 9p13.1 | 9.54e-04 | 24 | 87 | 2 | 9p13.1 | |
| Cytoband | 5p15.2 | 1.21e-03 | 27 | 87 | 2 | 5p15.2 | |
| Cytoband | 12p13.3 | 1.49e-03 | 30 | 87 | 2 | 12p13.3 | |
| GeneFamily | Arginine vasopressin and oxytocin receptors | 6.69e-05 | 4 | 61 | 2 | 259 | |
| GeneFamily | Blood group antigens|CD molecules|ATP binding cassette subfamily G | 1.11e-04 | 5 | 61 | 2 | 811 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.79e-06 | 149 | 81 | 5 | defe2e4a2f3118f8b42e99a4f2bf03e54c1b698f | |
| ToppCell | Entopeduncular-Macroglia-POLYDENDROCYTE-P1-P1_2|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.07e-05 | 75 | 81 | 4 | 9a82db6281326acc534b800e02b262a8617a147e | |
| ToppCell | Entopeduncular-Macroglia-POLYDENDROCYTE-P1-P1_2-Tnr-Polydendrocyte.Tnr.Pdgfa_(Pdgfa)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.07e-05 | 75 | 81 | 4 | 7678e7d514560c774b56fc0a20312d561c89f587 | |
| ToppCell | Entopeduncular-Macroglia-POLYDENDROCYTE-P1-P1_2-Tnr|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.07e-05 | 75 | 81 | 4 | 7f1fc575fca42352434f7188c7a95b50372aeefa | |
| Drug | Vasopressin | 3.56e-05 | 3 | 79 | 2 | DB00067 | |
| Drug | Terlipressin | 3.56e-05 | 3 | 79 | 2 | DB02638 | |
| Drug | Desmopressin | 3.56e-05 | 3 | 79 | 2 | DB00035 | |
| Drug | Mtpia-oxytocin | 3.56e-05 | 3 | 79 | 2 | CID003083145 | |
| Drug | NSC342736 | 3.56e-05 | 3 | 79 | 2 | CID000433641 | |
| Drug | Haloperidol [52-86-8]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 5.71e-05 | 193 | 79 | 6 | 5273_DN | |
| Drug | ST021200; Up 200; 10uM; PC3; HT_HG-U133A | 5.87e-05 | 194 | 79 | 6 | 7493_UP | |
| Drug | Cefsulodin sodium salt [52152-93-9]; Up 200; 7.2uM; MCF7; HT_HG-U133A | 6.04e-05 | 195 | 79 | 6 | 4148_UP | |
| Drug | Hymecromone [90-33-5]; Up 200; 22.8uM; MCF7; HT_HG-U133A | 6.22e-05 | 196 | 79 | 6 | 3383_UP | |
| Drug | Fluvoxamine maleate [61718-82-9]; Up 200; 9.2uM; HL60; HT_HG-U133A | 6.22e-05 | 196 | 79 | 6 | 2913_UP | |
| Drug | Merbromin [129-16-8]; Up 200; 5uM; PC3; HT_HG-U133A | 6.22e-05 | 196 | 79 | 6 | 3700_UP | |
| Drug | Oxalamine citrate salt [1949-20-8]; Up 200; 9.2uM; HL60; HT_HG-U133A | 6.22e-05 | 196 | 79 | 6 | 3006_UP | |
| Drug | benserazide hydrochloride; Down 200; 10uM; SKMEL5; HG-U133A | 6.22e-05 | 196 | 79 | 6 | 631_DN | |
| Drug | Ampyrone [83-07-8]; Down 200; 19.6uM; MCF7; HT_HG-U133A | 6.22e-05 | 196 | 79 | 6 | 2249_DN | |
| Drug | Dihydrostreptomycin sulfate [5490-27-7]; Up 200; 2.8uM; PC3; HT_HG-U133A | 6.40e-05 | 197 | 79 | 6 | 5751_UP | |
| Drug | Sulfamethizole [144-82-1]; Up 200; 14.8uM; PC3; HT_HG-U133A | 6.40e-05 | 197 | 79 | 6 | 5798_UP | |
| Drug | Catechin-(+,-) hydrate [7295-85-4]; Up 200; 13.8uM; PC3; HT_HG-U133A | 6.76e-05 | 199 | 79 | 6 | 4255_UP | |
| Drug | Paromomycin sulfate [1263-89-4]; Up 200; 5.6uM; PC3; HT_HG-U133A | 6.76e-05 | 199 | 79 | 6 | 4595_UP | |
| Drug | 2,2',4,6-tetrachlorobiphenyl | 7.10e-05 | 4 | 79 | 2 | ctd:C447028 | |
| Drug | Ac-VP | 7.10e-05 | 4 | 79 | 2 | CID000149364 | |
| Drug | D-Mlvp | 7.10e-05 | 4 | 79 | 2 | CID003083074 | |
| Disease | Intellectual Disability | 2.01e-06 | 447 | 75 | 9 | C3714756 | |
| Disease | portal hypertension (is_marker_for) | 9.50e-05 | 6 | 75 | 2 | DOID:10762 (is_marker_for) | |
| Disease | acute promyelocytic leukemia (is_implicated_in) | 1.33e-04 | 7 | 75 | 2 | DOID:0060318 (is_implicated_in) | |
| Disease | Precancerous Conditions | 1.81e-04 | 110 | 75 | 4 | C0032927 | |
| Disease | Condition, Preneoplastic | 1.81e-04 | 110 | 75 | 4 | C0282313 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 3.33e-04 | 364 | 75 | 6 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 6.19e-04 | 152 | 75 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | nevus count | 9.50e-04 | 18 | 75 | 2 | EFO_0004632 | |
| Disease | renovascular hypertension (biomarker_via_orthology) | 1.06e-03 | 19 | 75 | 2 | DOID:1591 (biomarker_via_orthology) | |
| Disease | response to antidepressant | 1.07e-03 | 176 | 75 | 4 | GO_0036276 | |
| Disease | cardiovascular system disease (is_implicated_in) | 1.30e-03 | 21 | 75 | 2 | DOID:1287 (is_implicated_in) | |
| Disease | migraine disorder, Headache | 1.39e-03 | 86 | 75 | 3 | HP_0002315, MONDO_0005277 | |
| Disease | body fat percentage | 1.52e-03 | 488 | 75 | 6 | EFO_0007800 | |
| Disease | IGF-1 measurement | 1.52e-03 | 488 | 75 | 6 | EFO_0004627 | |
| Disease | Neurodevelopmental Disorders | 1.74e-03 | 93 | 75 | 3 | C1535926 | |
| Disease | acute kidney failure (implicated_via_orthology) | 2.15e-03 | 27 | 75 | 2 | DOID:3021 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LRDTVLTHLRFMSHV | 386 | Q9H172 | |
| IMRDSVLTHLRITSH | 416 | P45844 | |
| VRLMRYRSHVLHSLL | 541 | Q9Y4B4 | |
| VSLEARLSRMHFHDS | 81 | Q9NQ90 | |
| REPHFTERTLHILMS | 741 | Q9NR16 | |
| SRLGIRMLATHHLAL | 196 | O14874 | |
| LLVDLLDHRMTEVHR | 596 | Q9UQB3 | |
| VRMFDLRHLEHSTII | 201 | P61962 | |
| ETTRHFLMSDRSLHL | 186 | P32121 | |
| EELIRTLLGAHTRHM | 111 | Q14994 | |
| FVLLDMVHSLLHRLS | 121 | Q5JQC4 | |
| SALRFQAMEETHLRH | 196 | O14526 | |
| EILDSHVRAHLRMKA | 1096 | M0R2J8 | |
| ILRRHLAEEMSAVFH | 666 | Q674X7 | |
| RRITRSILQMSLDHH | 606 | P19823 | |
| LSHSLEAEHRLLKAM | 381 | Q9HC44 | |
| TMLSHSFLEDVIRRL | 4136 | Q5CZC0 | |
| RHGFLILSREDSTMI | 571 | Q10570 | |
| GFIHEDHLRELLTTM | 116 | P24844 | |
| LQQMSERFLHHTRTL | 56 | Q9BQD3 | |
| ERFLHHTRTLVEMKR | 61 | Q9BQD3 | |
| MRDIILATDLAHHLR | 761 | O00408 | |
| ELTSMHTLLLREHNR | 411 | P05164 | |
| MDSSIHLSSLISRHD | 1 | Q9H8E8 | |
| RHFSHLSTLEREMAF | 46 | Q2PZI1 | |
| SEIMLHHCFASLLTR | 291 | O60928 | |
| EDARRSSHMLFTLHV | 596 | Q9ULI4 | |
| LLMLHRARITDVEHI | 881 | P22413 | |
| DRHFSHLSSLEREMT | 131 | Q6NUT2 | |
| RLLSREISSMEKLHH | 116 | Q8IY84 | |
| IIRHKDSMDELFSHR | 5721 | Q9UPN3 | |
| RMLADLLFTHRSITF | 81 | O60404 | |
| RMLADLLSTHHSITF | 81 | Q8NGA5 | |
| DITSTLHHLRMLDFR | 726 | Q92794 | |
| LHHLRMLDFRSDQFV | 731 | Q92794 | |
| EYLLRHLARMARHSA | 441 | O14559 | |
| YMRTLLDSIAHGHRL | 331 | Q9YNA8 | |
| YMRTLLDSIAHGHRL | 331 | P62683 | |
| YMRTLLDSIAHGHRL | 331 | Q7LDI9 | |
| YMRTLLDSIAHGHRL | 331 | P63130 | |
| YMRTLLDSIAHGHRL | 331 | P62685 | |
| YMRTLLDSIAHGHRL | 331 | P63126 | |
| YMRTLLDSIAHGHRL | 331 | P62684 | |
| MTEALLELHGHSRRV | 126 | Q9UQ03 | |
| SMRLEFLRILCSHEH | 1091 | Q8NF50 | |
| RHFHTLRMTIFCLVL | 196 | P51677 | |
| VARAMTHTLLRHLAA | 426 | Q6P531 | |
| LLHESMLSSVLHART | 161 | Q96LA8 | |
| HTSRSVRHFLDLFME | 856 | Q68D51 | |
| LDAVMSRLPHHSESR | 486 | Q8N4S9 | |
| RHNLSLHDMFVRETS | 286 | Q08050 | |
| LMHRDEQSRTLLHHA | 816 | Q13574 | |
| FLLSHLSLMDILHVS | 61 | Q8NGZ0 | |
| DLEEMTPLHLTTRHR | 111 | Q9Y283 | |
| ELHRHLSAMLSSTAR | 831 | Q9H0X9 | |
| CSISHLHSLFRVLLM | 186 | Q8NGR2 | |
| EFLLDLGHHERSIMT | 151 | Q9BYC5 | |
| ERLLLHDKDRMTVHS | 496 | Q9BYH1 | |
| HNVSFMELLSAHRRD | 801 | P29590 | |
| DVHFRMIHEDTRHLL | 606 | Q7Z3K3 | |
| HTHSLFTLLGERLML | 786 | Q8NFP9 | |
| ELHDLMAARRSKLVH | 1071 | Q8IWB4 | |
| MDHAFLLLSSEREHR | 451 | P49221 | |
| ILGSMRDEKRTHDHL | 466 | O60733 | |
| DLRLHEGTMRTTSHR | 31 | Q8NA69 | |
| RLSPLEHMRRHSVTD | 791 | Q17R89 | |
| VRHMRKLHLGSSLDS | 316 | Q8IU85 | |
| YMRTLLDSIAHGHRL | 331 | P63128 | |
| SRLHLESMLLETGHR | 196 | Q9BW66 | |
| LISHRIFIARMLAHT | 2041 | A5YKK6 | |
| ELHDLMAARRSKLVH | 1071 | Q5VYP0 | |
| LAHMLLICRFHSTED | 116 | Q9UL52 | |
| VREALFHLFSLTHVM | 341 | Q9C0D3 | |
| RSRMHLFVLHLALTD | 66 | P47901 | |
| FLDSLRLRMHLLAHS | 441 | Q05516 | |
| ELHDLMAARRSKLVH | 1071 | Q5TZJ5 | |
| ELHDLMAARRSKLVH | 1071 | Q5VU36 | |
| HQALLRHLESLATMS | 1146 | Q6ZMY3 | |
| MLGLTSHEAHFSLLR | 211 | Q8IZH2 | |
| PEETTFHLLHLSLMR | 241 | Q8IZH2 | |
| FISLVSIRRHMLTHR | 176 | Q7L945 | |
| RDMGITLHLLLHSDR | 66 | Q8WVM8 | |
| RMLVLFFLESELHEH | 466 | Q8WVM7 | |
| SHLHRMLHRDSTISN | 691 | Q2NKQ1 | |
| MHLFIRHLSLADLAV | 86 | P37288 | |
| HFDMLRLVTILEHRL | 86 | O43543 | |
| ETLMEREHTDTLRHL | 816 | Q8IYT8 | |
| DLLLRHSALRHMISF | 2301 | Q9UPU5 | |
| IHSSMILRFLHRNRL | 181 | O43149 | |
| LRSHERSHLALAMFT | 2006 | Q96JM2 | |
| MERREHLTLTFHSPE | 1 | A6NGA9 | |
| AHHERIHTMESFLTL | 536 | Q96ND8 | |
| VSTMLDRLHSTRQHL | 311 | O75962 | |
| FGLHLRLTSLHTMEF | 151 | Q99608 |